within Pharmacolibrary.Drugs.ATC.N;

model N01AH51
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 34 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,
    adminCount     = 1,
    Vd             = 0.012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Fentanyl is a potent synthetic opioid analgesic, often used for pain management and anesthesia. Combinations with other agents are typically designed for procedural sedation or balanced anesthesia. Fentanyl and its combinations are approved for clinical use but are subject to strict regulations due to the high risk of abuse and overdose.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for adults receiving intravenous fentanyl in combination with other anesthetic agents. No specific publication identified for fentanyl combinations with this ATC classification.</p><h4>References</h4><ol><li><p>Ziesenitz, VC, et al., &amp; van den Anker, JN (2018). Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review. <i>Clinical pharmacokinetics</i> 57(2) 125–149. DOI:<a href=&quot;https://doi.org/10.1007/s40262-017-0569-6&quot;>10.1007/s40262-017-0569-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28688027/&quot;>https://pubmed.ncbi.nlm.nih.gov/28688027</a></p></li><li><p>Scholz, J, et al., &amp; Schulz, M (1996). Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. <i>Clinical pharmacokinetics</i> 31(4) 275–292. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199631040-00004&quot;>10.2165/00003088-199631040-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8896944/&quot;>https://pubmed.ncbi.nlm.nih.gov/8896944</a></p></li><li><p>Hughes, LM, et al., &amp; Nestor, CC (2023). Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review. <i>Anaesthesia</i> 78(5) 620–625. DOI:<a href=&quot;https://doi.org/10.1111/anae.15952&quot;>10.1111/anae.15952</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36562193/&quot;>https://pubmed.ncbi.nlm.nih.gov/36562193</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N01AH51;
